Next Generation Dx Summit 2022 Agenda and Plenary Panels Announced: Legislative Efforts to Modernize Dx Oversight and Lessons From the Pandemic
2 followers
0 Likes
Let's advance diagnostics together by gathering at CHI's 14th annual Next Generation Dx Summit on August 22-24, 2022, in Washington, D.C. The Next Generation Dx Summit is the nexus for key opinion leaders across the world to share recent progress in diagnostic advancement and technology innovation. The event provides a valuable window on how point-of-care, infectious disease, liquid biopsy and companion diagnostics are changing the standard of care. Those who can't attend in-person may participate virtually.
PLENARY PANEL DISCUSIONS:
Legislative Efforts to Modernize Diagnostic Oversight
PANEL MODERATOR:
Cynthia A. Bens, Senior Vice President, Public Policy, Personalized Medicine Coalition
PLENARY PANEL DISCUSIONS:
Legislative Efforts to Modernize Diagnostic Oversight
PANEL MODERATOR:
Cynthia A. Bens, Senior Vice President, Public Policy, Personalized Medicine Coalition
PANELISTS:
Jeff Allen, PhD, Executive Director, Friends of Cancer Research
Sarah Thibault-Sennett, PhD Director, Public Policy & Advocacy, Association for Molecular Pathology
Lauren R. Silvis, PhD, Senior Vice President, External Affairs, Tempus, Inc.
Thomas Sparkman, JD, Senior Vice President, Government Affairs and Policy, American Clinical Laboratory Association
Susan Van Meter, Executive Director, AdvaMed
Self-Testing: Applying What We Have Learned From the Pandemic for Future Applications
PANEL MODERATOR:
Franklin R. Cockerill III, MD, Founding Partner, Trusted Health Advisors; Adjunct Professor, Medicine, Rush University
Jeff Allen, PhD, Executive Director, Friends of Cancer Research
Sarah Thibault-Sennett, PhD Director, Public Policy & Advocacy, Association for Molecular Pathology
Lauren R. Silvis, PhD, Senior Vice President, External Affairs, Tempus, Inc.
Thomas Sparkman, JD, Senior Vice President, Government Affairs and Policy, American Clinical Laboratory Association
Susan Van Meter, Executive Director, AdvaMed
Self-Testing: Applying What We Have Learned From the Pandemic for Future Applications
PANEL MODERATOR:
Franklin R. Cockerill III, MD, Founding Partner, Trusted Health Advisors; Adjunct Professor, Medicine, Rush University
PANELISTS:
Karen A. Heichman, PhD, Deputy Director, Bill & Melinda Gates Foundation
Jack Jeng, MD, MBA, Director, Medical Affairs, BD
Elizabeth M. Marlowe, PhD, D(ABMM) Senior Scientific Director, Head R&D Infectious Diseases & Immunology, Quest Diagnostics Nichols Institute
Donna M. Wolk, PhD, Chief, Molecular & Microbial Diagnostics & Development, Geisinger Health System
Nicole Zitterkopf, PhD, D(ABMM), MPH, MT(ASCP), Vice President Laboratory, Service Line Advancement Team, OptumHealth
To register and view full details: www.NextGenerationDx.com or call CHI at +1 781-972-5400.
Karen A. Heichman, PhD, Deputy Director, Bill & Melinda Gates Foundation
Jack Jeng, MD, MBA, Director, Medical Affairs, BD
Elizabeth M. Marlowe, PhD, D(ABMM) Senior Scientific Director, Head R&D Infectious Diseases & Immunology, Quest Diagnostics Nichols Institute
Donna M. Wolk, PhD, Chief, Molecular & Microbial Diagnostics & Development, Geisinger Health System
Nicole Zitterkopf, PhD, D(ABMM), MPH, MT(ASCP), Vice President Laboratory, Service Line Advancement Team, OptumHealth
To register and view full details: www.NextGenerationDx.com or call CHI at +1 781-972-5400.
0 Replies
Reply
Subgroup Membership is required to post Replies
Join POCT Listserv now
Suggested Posts
| Topic | Replies | Likes | Views | Participants | Last Reply |
|---|---|---|---|---|---|
| Roche Chemstrip specific gravity | 1 | 0 | 114 | ||
| Anybody have experience with the Actalyke? | 0 | 0 | 149 | ||
| Cal/Ver Istat pCO2 | 2 | 0 | 270 |